Drug Delivery: Transdermal Devices

This comprehensive medical market and technology report provides a comprehensive discussion of transdermal drug delivery technology for the treatment of cardiovascular disease (CVD), neurological disorders, hormone replacement therapy (HRT), pain management, and genitourinary disorder management. Markets covered by this analysis include the US, Japan, the five major EU markets (France,Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets.